🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Exciting day! 🎉 Today we celebrate the 1st Annual Internal Meeting of the THRIVE Consortium, focused on improving outcomes for pediatric and adult liver cancer. Looking forward to meaningful discussions and progress! 💪 #THRIVEConsortium #LiverCancer #Research #Livertwitter

nature.com/articles/s4158… Really proud of this fantastic work from a wonderful team that I have been privileged to work with.

nature Hospital Clínic HUNTER: Hepatocellular Carcinoma Expediter Network THRIVE Liver Cancer EU Project 🆕Un estudio publicado en nature, en el que han participado el #CLÍNIC-#IDIBAPS describe 25 nuevos modelos de ratón que reproducen el carcinoma hepatocelular y permiten probar terapias personalizadas Hospital Clínic HUNTER: Hepatocellular Carcinoma Expediter Network THRIVE Liver Cancer EU Project  👉s.mtrbio.com/akdylphfqp

Nature research paper: Human-correlated genetic models identify precision therapy for liver cancer go.nature.com/4gTUJog

Los #inmunoterapia es el camino, en general en combinación, y para los pacientes que no responden habrá que ir buscando/probando alternativas. JM Llovet IDIBAPS en #AEEH2025

🏆¡Momentazo en #50CongresoAEEH! Manuel Romero-Gómez y Rocio aller entregan las Becas y Premios #AEEH. ✔️Premios #RisingStars para los jóvenes Elisa Pose y Bruno Ramos Bruno Ramos-Molina, PhD ✔️Mejor comunicación oral clínica para Ugne Balaseviute (IDIBAPS BCN) Mejor comunicación oral básica

👏Magnífica exposición de la ganadora de la Mejor Comunicación Oral del #50CongresoAEEH Ugne Balaseviciute, del Hospital Clínic. ✔️El microbioma intratumoral en el #CHC y su impacto en la respuesta al tratamiento. 🗣️"Bacillus prevalence was significantly higher in responders,

‼️Our latest publication in Journal of Hepatology ‼️ ✅Response to atezo+bev in HCC is immune- vs angiogenesis-driven. ⛔️Resistance is associated with immunosuppressive myeloid cells and Notch activation. 👉Molecular subgroups define distinct clinical outcomes. journal-of-hepatology.eu/article/S0168-…

🌍💚 This #WorldLiverDay (April 19, 2025), let's raise awareness about liver health! Protect your liver with healthy habits, check-ups, and lifestyle choices. 🥦💪Small steps today, healthier tomorrow! #LiverHealth #Prevention #HealthyLiver #Wellness EASLnews European Liver Patients' Association

Meet THRIVE Liver Cancer EU Project representatives at #EASLCongress next week and learn more about the project! When: Thursday 8 May, 10:00-10:30 Where: Track Hub 3, Liver Tumours More information: easlcongress.eu/2025-track-hub…

🎉 Excited to be part of #EASLCongress 2025! We’re sharing our latest research across multiple sessions. Check out all our presentations below ⬇️ #Livertwitter

🌷The Basic Science Seminar at #EASLCongress delves into the exposome and liver carcinogenesis, as we explore how environmental and metabolic factors fuel liver tumour development. From the physiopathology of hepatocarcinogenesis with or without cirrhosis, to the disruptive role

📢 Last week we shared the Understanding Cluster video. Now, explore the science behind it in our brochure 👉rb.gy/t6eglw Funded by HaDEA, Hit Glio, THRIVE Liver Cancer EU Project, SPACETIME_EU Project, ARTURO, GLIOMATCH & #MULTIR_EU are advancing cancer research 🤝 #EUCancerMission

Jessica Zucman Rossi & Théo Hirsh conclude the #EASLCongress BSS on day 1 with an integrated view of personalised medicine in HCC & hepatoblastoma. 🔝👌🏼 Much more basic/translational sessions on days 2-4; check the EASL website/app! EASLnews #livertwitter

Thank you EASLnews for giving me the opportunity to present our work on hepatoblastoma genomics and future therapies together with my mentor Jessica Zucman-Rossi

Don’t miss our networking session today from 10:00 to 10:30!. We’re excited to share our project and its impact. #Livertwitter #EASLCongress